UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Clinical cancer research, ISSN 1078-0432, 10/2013, Volume 19, Issue 19, pp. 5505 - 5512
Life Sciences & Biomedicine | Oncology | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Pharmacology. Drug treatments | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Antineoplastic agents | Tumors | Anilides - therapeutic use | Receptors, Estrogen - metabolism | Anilides - adverse effects | Humans | Middle Aged | Receptors, Androgen - metabolism | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Breast Neoplasms - metabolism | Nitriles - administration & dosage | Neoplasm Metastasis | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Hormones - blood | Tosyl Compounds - administration & dosage | Treatment Outcome | Breast Neoplasms - drug therapy | Tosyl Compounds - adverse effects | Anilides - administration & dosage | Breast Neoplasms - pathology | Tosyl Compounds - therapeutic use | Androgen Antagonists - therapeutic use | Breast Neoplasms - mortality | Aged | Androgen Antagonists - administration & dosage | Androgen Antagonists - adverse effects | Nitriles - adverse effects | Nitriles - therapeutic use | Index Medicus
Journal Article
Endocrine-related cancer, ISSN 1351-0088, 08/2014, Volume 21, Issue 4, pp. T105 - T118
Thematic Review | Antiandrogen | Bicalutamide | Androgen receptor antagonist | Enzalutamide | Abiraterone | Prostate cancer | Oncology | Endocrinology & Metabolism | Life Sciences & Biomedicine | Science & Technology | Prostatic Neoplasms - metabolism | Androgen Receptor Antagonists - therapeutic use | Humans | Receptors, Androgen - metabolism | Male | Antineoplastic Agents - therapeutic use | Androgen Receptor Antagonists - pharmacology | Antineoplastic Agents - chemistry | Animals | Castration | Androgen Receptor Antagonists - chemistry | Antineoplastic Agents - pharmacology | Prostatic Neoplasms - drug therapy | Index Medicus
Journal Article
Cell (Cambridge), ISSN 0092-8674, 12/2013, Volume 155, Issue 6, pp. 1309 - 1322
Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Neoplasm Transplantation | Androgen Receptor Antagonists - therapeutic use | Phenylthiohydantoin - therapeutic use | Humans | Receptors, Androgen - metabolism | Gene Expression Regulation | Transcriptome | Drug Resistance, Neoplasm | Male | Receptors, Glucocorticoid - metabolism | Phenylthiohydantoin - analogs & derivatives | Animals | Heterografts | Androgen Antagonists - therapeutic use | Mice | Prostatic Neoplasms - drug therapy | Disease Models, Animal | Index Medicus
Journal Article
Current medicinal chemistry, ISSN 0929-8673, 01/2019, Volume 26, Issue 33, pp. 6053 - 6073
Pharmacology & Pharmacy | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Phenylthiohydantoin - chemistry | Anilides - therapeutic use | Androgen Receptor Antagonists - therapeutic use | Phenylthiohydantoin - therapeutic use | Humans | Receptors, Androgen - metabolism | Anilides - chemistry | Androstenes - therapeutic use | Drug Resistance, Neoplasm | Male | Tosyl Compounds - chemistry | Histone Deacetylase Inhibitors - chemistry | Phenylthiohydantoin - analogs & derivatives | Androstenes - chemistry | Receptors, Androgen - genetics | Androgen Receptor Antagonists - chemistry | Tosyl Compounds - therapeutic use | Nitriles - chemistry | Receptors, Androgen - chemistry | Histone Deacetylase Inhibitors - therapeutic use | Prostatic Neoplasms - drug therapy | Nitriles - therapeutic use | Surveys | Cytochrome | Organic chemistry | Androgens | Castration | Pathogenesis | Cytochrome P450 | Prostate cancer | Prostate | Cancer | Cytochromes P450
Journal Article
Journal of medicinal chemistry, ISSN 0022-2623, 04/2010, Volume 53, Issue 7, pp. 2779 - 2796
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Prostatic Neoplasms - pathology | Androgen Receptor Antagonists | Prostatic Neoplasms - surgery | Thiohydantoins - pharmacology | Receptors, Androgen - metabolism | Male | Structure-Activity Relationship | Thiohydantoins - chemical synthesis | Orchiectomy | Dose-Response Relationship, Drug | Xenograft Model Antitumor Assays | Androgens | Animals | Prostatic Neoplasms - genetics | Tumor Burden - drug effects | Thiohydantoins - therapeutic use | Cell Line, Tumor | Gene Expression Regulation, Neoplastic - drug effects | Thiohydantoins - chemistry | Prostatic Neoplasms - drug therapy | Index Medicus
Journal Article
Journal of molecular endocrinology, ISSN 0952-5041, 06/2014, Volume 52, Issue 3, pp. R257 - R265
Review | Steroid | Breast cancer | Androgen receptors | Oestrogen receptor | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Steroid 17-alpha-Hydroxylase - antagonists & inhibitors | Anilides - therapeutic use | Signal Transduction | Humans | Receptors, Androgen - metabolism | Receptors, Estrogen - antagonists & inhibitors | Estrogen Antagonists - pharmacology | Triple Negative Breast Neoplasms - drug therapy | Abiraterone Acetate | Estrogen Antagonists - therapeutic use | Tamoxifen - therapeutic use | Tosyl Compounds - therapeutic use | Tamoxifen - pharmacology | Triple Negative Breast Neoplasms - pathology | Androgen Antagonists - therapeutic use | Female | Androstadienes - therapeutic use | Androgens - metabolism | Nitriles - therapeutic use | Index Medicus
Journal Article
The cancer journal (Sudbury, Mass.), ISSN 1528-9117, 01/2013, Volume 19, Issue 1, pp. 43 - 49
androgen receptor antagonists | androgen receptor | antiandrogens | ARN-509 | Prostate cancer | enzalutamide | Life Sciences & Biomedicine | Oncology | Science & Technology | Prostatic Neoplasms - pathology | Androgen Receptor Antagonists - therapeutic use | Prostatic Neoplasms - surgery | Thiohydantoins - pharmacology | Humans | Receptors, Androgen - metabolism | Male | Clinical Trials as Topic | Orchiectomy | Animals | Antineoplastic Agents, Hormonal - therapeutic use | Thiohydantoins - therapeutic use | Neoplasm Staging | Prostatic Neoplasms - drug therapy | Index Medicus | prostate cancer
Journal Article
Drug discovery today, ISSN 1359-6446, 2007, Volume 12, Issue 5, pp. 241 - 248
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Hormones. Endocrine system | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Androgen Antagonists - pharmacokinetics | Androgen Receptor Antagonists | Humans | Androgen Antagonists - pharmacology | Male | Organ Specificity | Drug Delivery Systems | Gene Expression Regulation - drug effects | Tissue Distribution | Androgens - pharmacology | Drug Design | Androgen Antagonists - therapeutic use | Androgens - pharmacokinetics | Androgens - therapeutic use | Female | Ligands | Index Medicus
Journal Article
9.
Full Text
Role of androgen receptor splice variants, their clinical relevance and treatment options
World journal of urology, ISSN 0724-4983, 2019, Volume 38, Issue 3, pp. 647 - 656
Splice variant | Clinical relevance | AR-V | Androgen receptor | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Prostatic Neoplasms - metabolism | Alternative Splicing | Humans | Receptors, Androgen - metabolism | Gene Expression Regulation, Neoplastic | Male | RNA, Messenger - metabolism | Protein Domains - genetics | Prostatic Neoplasms, Castration-Resistant - genetics | Benzamides - therapeutic use | Prostatic Neoplasms - genetics | Protein Isoforms - metabolism | Antineoplastic Agents, Hormonal - therapeutic use | Isoindoles - therapeutic use | Lactams, Macrocyclic - therapeutic use | Benzhydryl Compounds - therapeutic use | Prostatic Neoplasms - drug therapy | Benzimidazoles - therapeutic use | Chlorohydrins - therapeutic use | RNA, Messenger - genetics | Binding Sites - genetics | Prostatic Neoplasms, Castration-Resistant - drug therapy | Enzyme Inhibitors - therapeutic use | Prostatic Neoplasms, Castration-Resistant - metabolism | Resorcinols - therapeutic use | Drug Resistance, Neoplasm - genetics | Receptors, Androgen - genetics | HSP90 Heat-Shock Proteins - antagonists & inhibitors | Androgen Antagonists - therapeutic use | Androstadienes - therapeutic use | Isoxazoles - therapeutic use | Benzoquinones - therapeutic use | Proteins - antagonists & inhibitors | Niclosamide - therapeutic use | Protein Isoforms - genetics | Literature reviews | Alternative splicing | Androgens | Transcription | Clinical trials | Endocrine therapy | Prostate | Prostate cancer | Index Medicus
Journal Article